cas 1266132-36-8|| where to buy 1-piperidin-4-ylcyclopropan-1-amine

Nom du produit:1-piperidin-4-ylcyclopropan-1-amine

IUPAC Name:1-(piperidin-4-yl)cyclopropan-1-amine

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1266132-36-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1266132-36-8; Formule moléculaire:C8H16N2; Point de fusion:-; Code SMILES:NC1(C2CCNCC2)CC1; Densité:

: Numéro de catalogue:CM327275; Poids moléculaire:140.23; Point d'ébullition:; N° Mdl:; Stockage:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.